Articles de revues sur le sujet « Fragmentomics »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Fragmentomics ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Kohabir, Kavish, Rob Wolthuis, and Erik A. Sistermans. "Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond." Journal of Biomedicine and Translational Research 7, no. 1 (2021): 38–47. http://dx.doi.org/10.14710/jbtr.v7i1.10229.
Texte intégralDing, Spencer C., and Y. M. Dennis Lo. "Cell-Free DNA Fragmentomics in Liquid Biopsy." Diagnostics 12, no. 4 (2022): 978. http://dx.doi.org/10.3390/diagnostics12040978.
Texte intégralYang, Yin, Tao Zhang, Jingbo Wang, et al. "Abstract 5400: Predicting disease progression in inoperable localized NSCLC patients using cfDNA fragmentomics assay." Cancer Research 83, no. 7_Supplement (2023): 5400. http://dx.doi.org/10.1158/1538-7445.am2023-5400.
Texte intégralZhao, Huan, Shuang Gan, Hang Dong, et al. "Use of urinary cell-free DNA fragmentomics in urothelial carcinoma diagnosis." Journal of Clinical Oncology 43, no. 5_suppl (2025): 846. https://doi.org/10.1200/jco.2025.43.5_suppl.846.
Texte intégralCobb, Meagan S., Philippe Jolivet, Kristen N. Ganjoo, Deirdre A. Lum, Matt van de Rijn, and Joanna Przybyl. "Abstract 3678: Liquid biopsy fragmentomics approach for the diagnosis of uterine tumors." Cancer Research 85, no. 8_Supplement_1 (2025): 3678. https://doi.org/10.1158/1538-7445.am2025-3678.
Texte intégralPan, Alex C., Russell Taylor Sundby, Jeffrey J. Szymanski, et al. "Abstract 997: Cell-free DNA fragmentomics distinguish between benign, pre-malignant and malignant peripheral nerve sheath tumors in neurofibromatosis type 1." Cancer Research 83, no. 7_Supplement (2023): 997. http://dx.doi.org/10.1158/1538-7445.am2023-997.
Texte intégralQi, Ting, Min Pan, Huajuan Shi, Liangying Wang, Yunfei Bai, and Qinyu Ge. "Cell-Free DNA Fragmentomics: The Novel Promising Biomarker." International Journal of Molecular Sciences 24, no. 2 (2023): 1503. http://dx.doi.org/10.3390/ijms24021503.
Texte intégralZamyatnin, A. A. "Fragmentomics of natural peptide structures." Biochemistry (Moscow) 74, no. 13 (2009): 1575–85. http://dx.doi.org/10.1134/s0006297909130100.
Texte intégralWang, Mengchi, Jin Mo Ahn, Junnam Lee, et al. "Abstract 4928: REFINE Method: Novel strategy for signal enhancement." Cancer Research 84, no. 6_Supplement (2024): 4928. http://dx.doi.org/10.1158/1538-7445.am2024-4928.
Texte intégralZamyatnin, A. A. "Fragmentomics of proteins and natural oligopeptides." Biophysics 53, no. 5 (2008): 329–35. http://dx.doi.org/10.1134/s0006350908050011.
Texte intégralThierry, A. R. "Circulating DNA fragmentomics and cancer screening." Cell Genomics 3, no. 1 (2023): 100242. http://dx.doi.org/10.1016/j.xgen.2022.100242.
Texte intégralDai, Chao, Lisha Zhu, Yong Huang, et al. "Abstract 940: Integrated analysis of cfDNA fragmentomics, DNA methylation and cfRNA transcription in metastatic castration-resistant prostate cancer (mCRPC)." Cancer Research 84, no. 6_Supplement (2024): 940. http://dx.doi.org/10.1158/1538-7445.am2024-940.
Texte intégralYin, Lingdi, Cheng Cao, Jianzhen Lin, et al. "Fragmentomics of cell-free DNA as a sensitive biomarker for early detection of pancreatic cancer." Journal of Clinical Oncology 42, no. 16_suppl (2024): 4173. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.4173.
Texte intégralLiu, Yaping. "At the dawn: cell-free DNA fragmentomics and gene regulation." British Journal of Cancer 126, no. 3 (2021): 379–90. http://dx.doi.org/10.1038/s41416-021-01635-z.
Texte intégralXu, Shun, Ji Luo, Wanxiangfu Tang, et al. "Abstract 5394: Detecting pulmonary malignancy against benign nodules using non-invasive cfDNA fragmentomics assay." Cancer Research 83, no. 7_Supplement (2023): 5394. http://dx.doi.org/10.1158/1538-7445.am2023-5394.
Texte intégralGan, Shuang, Haoran Tang, Feng Xie, Yue Zhang, and Hang Dong. "Abstract 6611: Genome-wide cfDNA fragmentomics combined with machine learning enhance non-invasive prostate cancer detection." Cancer Research 85, no. 8_Supplement_1 (2025): 6611. https://doi.org/10.1158/1538-7445.am2025-6611.
Texte intégralVillanueva-Cañas, J. L., D. Rizo-Potau, A. Fornies, et al. "Characterization of global cfDNA fragmentomics in Melanoma Patients." EJC Skin Cancer 3 (2025): 100432. https://doi.org/10.1016/j.ejcskn.2025.100432.
Texte intégralZhang, Ruiyun, Hang Dong, Shuang Gan, et al. "Applying fragmentomics profiles of urinary cell-free DNA for bladder cancer detection." Journal of Clinical Oncology 42, no. 4_suppl (2024): 671. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.671.
Texte intégralGrisolia, Piera, Antonio De Falco, Rossella Tufano, et al. "Advanced CNA-informed fragmentomics enhances cross-cohort tumor detection." Journal of Liquid Biopsy 5 (November 2024): 100256. http://dx.doi.org/10.1016/j.jlb.2024.100256.
Texte intégralZhu, Lisha, Chao Dai, Shuang Gan, Shidong Jia, and Pan Du. "Abstract 5884: Cancer subtype classification by cfDNA fragmentomics analysis." Cancer Research 85, no. 8_Supplement_1 (2025): 5884. https://doi.org/10.1158/1538-7445.am2025-5884.
Texte intégralShan, Zhen, Wanna Chen, Bo Lin, et al. "A non-invasive cfDNA fragmentomics assay for differentiating malignant and benign thyroid nodules." Journal of Clinical Oncology 42, no. 16_suppl (2024): 6110. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.6110.
Texte intégralLiu, Jiaqi, Yalun Li, Wanxiangfu Tang, et al. "Detecting early stage breast cancer using low-depth cell-free DNA fragmentomics: A multi-center cohort study." Journal of Clinical Oncology 41, no. 16_suppl (2023): 3075. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3075.
Texte intégralPeng, Yulu, Tingxuan Huang, Zhaohui Zhou, et al. "Early detection of renal cell carcinoma: A novel cfDNA fragmentomics-based liquid biopsy assay." Journal of Clinical Oncology 43, no. 16_suppl (2025): 4534. https://doi.org/10.1200/jco.2025.43.16_suppl.4534.
Texte intégralZhong, Yunshi, Dong-Li He, Zhi-Guo Xiong, et al. "GaEsSeer: Early detection of gastric and esophageal cancer by integrating methylation and fragmentomics signatures in cfDNA." Journal of Clinical Oncology 41, no. 16_suppl (2023): 4069. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.4069.
Texte intégralZhu, Lisha, Chao Dai, Shuang Gan, Shidong Jia, and Pan Du. "Abstract 3505: Classification of cancer subtypes by cfDNA fragmentomics analysis." Cancer Research 84, no. 6_Supplement (2024): 3505. http://dx.doi.org/10.1158/1538-7445.am2024-3505.
Texte intégralChiu, Rossa W. K., Ellen Heitzer, Y. M. Dennis Lo, Florent Mouliere, and Dana W. Y. Tsui. "Cell-Free DNA Fragmentomics: The New “Omics” on the Block." Clinical Chemistry 66, no. 12 (2020): 1480–84. http://dx.doi.org/10.1093/clinchem/hvaa258.
Texte intégralWang, Jiwen, Xiaojian Ni, Yuxuan Zheng, et al. "Integration of cfDNA fragmentomics for early biliary tract cancer detection." Journal of Clinical Oncology 43, no. 16_suppl (2025): 4131. https://doi.org/10.1200/jco.2025.43.16_suppl.4131.
Texte intégralMaansson, Christoffer Trier, Louise Skov Thomsen, Peter Meldgaard, Anders Lade Nielsen, and Boe Sandahl Sorensen. "Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies." International Journal of Molecular Sciences 25, no. 2 (2024): 1243. http://dx.doi.org/10.3390/ijms25021243.
Texte intégralJiao, Zichen, Xiaoqiang Zhang, Yulong Xuan, et al. "Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma." Journal of Clinical Oncology 42, no. 16_suppl (2024): 4054. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.4054.
Texte intégralTaylor, Amy K., Kyle Helzer, Marina Nasrin Sharifi, et al. "Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies." Journal of Clinical Oncology 42, no. 4_suppl (2024): 199. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.199.
Texte intégralPark, Sehhoon, Jun-Kyu Kang, Hwang-Phill Kim, et al. "Exploratory analysis using cfDNA-based fragmentomics to predict disease recurrence in limited disease small cell lung cancer." Journal of Clinical Oncology 40, no. 16_suppl (2022): 8569. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.8569.
Texte intégralPark, Sehhoon, Jun-Kyu Kang, Hwang-Phill Kim, et al. "Exploratory analysis using cfDNA-based fragmentomics to predict disease recurrence in limited disease small cell lung cancer." Journal of Clinical Oncology 40, no. 16_suppl (2022): 8569. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.8569.
Texte intégralChauhan, Pradeep Singh, Irfan Alahi, Jessica Linford, et al. "Abstract 3258: Predicting genitourinary cancer tissue-of-origin using urine cell-free DNA fragmentomics and cell-free RNA." Cancer Research 85, no. 8_Supplement_1 (2025): 3258. https://doi.org/10.1158/1538-7445.am2025-3258.
Texte intégralLo, Y. M. Dennis, Diana S. C. Han, Peiyong Jiang, and Rossa W. K. Chiu. "Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies." Science 372, no. 6538 (2021): eaaw3616. http://dx.doi.org/10.1126/science.aaw3616.
Texte intégralRahat, Dolev, Lilach Schneor, Noa Liscovitch-Brauer, and Noam Shomron. "P125: Detection of pancreatic cancer in liquid biopsies using integrative fragmentomics." Genetics in Medicine Open 2 (2024): 101006. http://dx.doi.org/10.1016/j.gimo.2024.101006.
Texte intégralYin, Rong, Siwei Wang, Ming Li, et al. "Utilization of cell-free DNA fragmentomics in minimal residual disease detection for non-small cell lung cancer." Journal of Clinical Oncology 40, no. 16_suppl (2022): 3038. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.3038.
Texte intégralGuzman, Carlos, Michael L. Salmans, Mengchi Wang, Byung In Lee, and Andrew R. Carson. "Abstract B058: Novel machine learning lung cancer classifier shows significant correlation with cancer-specific fragmentomics features." Clinical Cancer Research 30, no. 21_Supplement (2024): B058. http://dx.doi.org/10.1158/1557-3265.liqbiop24-b058.
Texte intégralBao, Hua, Xiaoxi Chen, Min Wu, et al. "Abstract 1266: Development and performance of a multi-cancer early detection test utilizing plasma cfDNA fragmentomics: A large-scale, prospective, multicenter study." Cancer Research 84, no. 6_Supplement (2024): 1266. http://dx.doi.org/10.1158/1538-7445.am2024-1266.
Texte intégralAbelman, Dor D., Jenna Eagles, Aimee Wong, et al. "Abstract 3250: Tumor-independent monitoring of minimal residual disease in multiple myeloma using cfDNA fragmentomics." Cancer Research 85, no. 8_Supplement_1 (2025): 3250. https://doi.org/10.1158/1538-7445.am2025-3250.
Texte intégralMaansson, Christoffer Trier, Louise Skov Thomsen, Peter Meldgaard, Anders Lade Nielsen, and Boe Sandahl Sorensen. "Abstract 2290: Integration of cell-free DNA end motifs and fragment lengths can improve identification of active genes in liquid biopsies." Cancer Research 84, no. 6_Supplement (2024): 2290. http://dx.doi.org/10.1158/1538-7445.am2024-2290.
Texte intégralRolfo, Christian, and Alessandro Russo. "The Next Frontier for Colorectal Cancer Screening: Blood-Based Tests." Cancer Research 84, no. 19 (2024): 3128–29. http://dx.doi.org/10.1158/0008-5472.can-24-1620.
Texte intégralSirajee, Ahmad Salman, Debajyoti Kabiraj, and Subhajyoti De. "Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes." Translational Oncology 49 (November 2024): 102085. http://dx.doi.org/10.1016/j.tranon.2024.102085.
Texte intégralYang, Xin-Rong, Dong-Li He, Zhi-Guo Xiong, et al. "Detection and localization of gastrointestinal cancers based on multi-dimentional signatures from a single cfDNA targeted sequencing assay." Journal of Clinical Oncology 41, no. 16_suppl (2023): 4169. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.4169.
Texte intégralPatel, Kishen R., Anisha Mistry, Robert Monfries, et al. "Abstract 4560: Use of ctDNA fragmentomics as a predictive biomarker in locally advanced non-small cell lung cancer." Cancer Research 85, no. 8_Supplement_1 (2025): 4560. https://doi.org/10.1158/1538-7445.am2025-4560.
Texte intégralZhang, Mingguang, Qianhui Wan, Shiwen Mei, et al. "Early gastrointestinal tumour detection using cfDNA fragmentomes based on low-pass whole-genome sequencing (lp-WGS)." Journal of Clinical Oncology 41, no. 16_suppl (2023): e15511-e15511. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15511.
Texte intégralWang, Haichao, Paulius D. Mennea, Yu Kiu Elkie Chan, et al. "A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data." Genome Biology 26, no. 1 (2025): 141. https://doi.org/10.1186/s13059-025-03607-5.
Texte intégralAvgeris, Margaritis, Antonios Marmarinos, Dimitrios Gourgiotis, and Andreas Scorilas. "Jagged Ends of Cell-Free DNA: Rebranding Fragmentomics in Modern Liquid Biopsy Diagnostics." Clinical Chemistry 67, no. 4 (2021): 576–78. http://dx.doi.org/10.1093/clinchem/hvab036.
Texte intégralXu, Qin, Yibin Lin, Xiaoxi Chen, et al. "Early detection of uterine corpus endometrial carcinoma utilizing plasma cell-free DNA fragmentomics." Gynecologic Oncology 190 (November 2024): S32. http://dx.doi.org/10.1016/j.ygyno.2024.07.053.
Texte intégralXu, S., J. Luo, W. Tang, et al. "Detecting pulmonary malignancy against benign nodules using noninvasive cell-free DNA fragmentomics assay." ESMO Open 9, no. 8 (2024): 103595. http://dx.doi.org/10.1016/j.esmoop.2024.103595.
Texte intégralCao, Y., N. Wang, C. Si, et al. "585P Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer." Annals of Oncology 34 (October 2023): S426. http://dx.doi.org/10.1016/j.annonc.2023.09.1776.
Texte intégral